Incyte faces UK case from Sun Pharma over proposed alopecia drug
India's Sun Pharmaceutical Industries is bringing a case against US company Incyte in the UK to have a patent declared invalid and clear the way for it to roll out an...To view the full article, register now.
Already a subscriber? Click here to view full article